| Bioactivity | MLK-IN-1 is a potent, brain penetrant and specific mixed lineage kinase 3 (MLK-3) inhibitor, compound 68, extracted from patent US20140256733A1[1]. | ||||||||||||
| Invitro | MLK-IN-1 (100 nM; pre-treatment 20 mins HIV-1 Tat) promotes continued axonogenesis in the presence of Tat-activated microglia and protects against effects of HIV-Tat in vitro[1]. | ||||||||||||
| Name | MLK-IN-1 | ||||||||||||
| CAS | 1627729-62-7 | ||||||||||||
| Formula | C23H20N4O3S | ||||||||||||
| Molar Mass | 432.49 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Val S. Goodfellow,et al.Mixed lineage kinase inhibitors and method of treatments. Patent US20140256733A1. |
MLK-IN-1
CAS: 1627729-62-7 F: C23H20N4O3S W: 432.49
MLK-IN-1 is a potent, brain penetrant and specific mixed lineage kinase 3 (MLK-3) inhibitor, compound 68, extracted from
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.